Neuropace Inc (NPCE)

Healthcare Healthcare Services Healthcare Equipment & Supplies

Track Share on 𝕏

Stock chart

Ticker: NPCE Exchange: NMS

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale

Past 90 days

Value bought

Value sold

Net insiders buying

Trades (buy and sell)

Company data

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Total value
2024-04-26	2024-04-24	S Sale	ORBIMED ADVISORS LLC Major owner	1,000 -0.1% 14.06 100,000 USD	1,000 -0.1%	14.06	100,000 USD
2024-04-23	2024-04-23	S Sale	ORBIMED ADVISORS LLC Major owner	1,000 -0.6% 14.29 100,000 USD	1,000 -0.6%	14.29	100,000 USD
2024-04-23	2024-04-22	S Sale	ORBIMED ADVISORS LLC Major owner	1,000 -0.7% 14.05 100,000 USD	1,000 -0.7%	14.05	100,000 USD
2024-04-23	2024-04-19	S Sale	ORBIMED ADVISORS LLC Major owner	1,000 -0.5% 14.02 100,000 USD	1,000 -0.5%	14.02	100,000 USD
2024-04-18	2024-04-18	S Sale	ORBIMED ADVISORS LLC Major owner	2,623 -0.1% 14.06 36,879 USD	2,623 -0.1%	14.06	36,879 USD
2024-04-18	2024-04-17	S Sale	ORBIMED ADVISORS LLC Major owner	300 -0.0% 14.15 4,245 USD	300 -0.0%	14.15	4,245 USD
2024-04-18	2024-04-16	S Sale	ORBIMED ADVISORS LLC Major owner	14,069 -0.4% 14.01 197,107 USD	14,069 -0.4%	14.01	197,107 USD
2024-04-15	2024-04-12	S Sale	ORBIMED ADVISORS LLC Major owner	23,101 -0.7% 14.42 333,116 USD	23,101 -0.7%	14.42	333,116 USD
2024-04-15	2024-04-11	S Sale	ORBIMED ADVISORS LLC Major owner	461,899 -11.5% 14.49 6,692,917 USD	461,899 -11.5%	14.49	6,692,917 USD
2024-02-06	2024-02-05	PS Planned sale	Morrell Martha Chief Medical Officer Officer	3,446 -4.2% 15.17 52,278 USD	3,446 -4.2%	15.17	52,278 USD
2024-02-06	2024-02-02	PS Planned sale	Morrell Martha Chief Medical Officer Officer	14,143 -14.8% 15.07 213,122 USD	14,143 -14.8%	15.07	213,122 USD
2024-02-01	2024-02-01	PS Planned sale	Morrell Martha Chief Medical Officer Officer	663 -0.7% 15.04 9,971 USD	663 -0.7%	15.04	9,971 USD
2024-02-01	2024-01-31	PS Planned sale	Morrell Martha Chief Medical Officer Officer	1,923 -2.0% 15.08 28,990 USD	1,923 -2.0%	15.08	28,990 USD
2024-02-01	2024-01-30	PS Planned sale	Morrell Martha Chief Medical Officer Officer	11,262 -10.3% 15.10 170,004 USD	11,262 -10.3%	15.10	170,004 USD
2024-01-26	2024-01-25	PS Planned sale	Morrell Martha Chief Medical Officer Officer	1 -0.0% 15.00 15 USD	1 -0.0%	15.00	15 USD
2024-01-26	2024-01-24	PS Planned sale	Morrell Martha Chief Medical Officer Officer	827 -0.8% 15.03 12,426 USD	827 -0.8%	15.03	12,426 USD
2023-12-28	2023-12-27	PS Planned sale	Morrell Martha Chief Medical Officer Officer	13,300 -10.8% 10.12 134,648 USD	13,300 -10.8%	10.12	134,648 USD
2023-12-28	2023-12-26	PS Planned sale	Morrell Martha Chief Medical Officer Officer	102 -0.1% 10.00 1,020 USD	102 -0.1%	10.00	1,020 USD
2023-12-22	2023-12-20	PS Planned sale	Morrell Martha Chief Medical Officer Officer	2,730 -2.2% 10.14 27,695 USD	2,730 -2.2%	10.14	27,695 USD
2023-12-07	2023-12-06	PS Planned sale	Morrell Martha Chief Medical Officer Officer	11,005 -8.0% 8.16 89,773 USD	11,005 -8.0%	8.16	89,773 USD
2023-12-01	2023-12-01	S Sale	KCK LTD. Major owner	3,241 -0.1% 8.73 28,294 USD	3,241 -0.1%	8.73	28,294 USD
2023-12-01	2023-11-30	S Sale	KCK LTD. Major owner	7,282 -0.1% 8.84 64,373 USD	7,282 -0.1%	8.84	64,373 USD
2023-12-01	2023-11-29	S Sale	KCK LTD. Major owner	5,644 -0.1% 8.72 49,216 USD	5,644 -0.1%	8.72	49,216 USD
2023-11-29	2023-11-28	S Sale	KCK LTD. Major owner	4,681 -0.1% 8.75 40,959 USD	4,681 -0.1%	8.75	40,959 USD
2023-11-29	2023-11-27	S Sale	KCK LTD. Major owner	6,490 -0.1% 8.96 58,150 USD	6,490 -0.1%	8.96	58,150 USD
2023-10-04	2023-10-03	S Sale	ORBIMED ADVISORS LLC Major owner	700 -0.0% 9.02 6,314 USD	700 -0.0%	9.02	6,314 USD
2023-10-04	2023-10-02	S Sale	ORBIMED ADVISORS LLC Major owner	7,614 -0.2% 9.08 69,135 USD	7,614 -0.2%	9.08	69,135 USD
2022-11-23	2022-11-22	B Purchase	Accelmed Partners II L.P. Major owner	62,398 +1.4% 1.50 93,535 USD	62,398 +1.4%	1.50	93,535 USD
2022-11-23	2022-11-21	B Purchase	Accelmed Partners II L.P. Major owner	327,893 +8.1% 1.50 491,512 USD	327,893 +8.1%	1.50	491,512 USD
2022-06-09	2022-06-08	PS Planned sale	Ridley Irina General Counsel and Secretary Officer	2,500 -3.9% 5.78 14,445 USD	2,500 -3.9%	5.78	14,445 USD
2022-03-01	2022-02-28	PS Planned sale	Ridley Irina General Counsel and Secretary Officer	1,470 -18.1% 7.54 11,082 USD	1,470 -18.1%	7.54	11,082 USD
2021-04-23	2021-04-21	B Purchase	Norton Evan Non-Executive Director	588,235 +inf% 17.00 9,999,995 USD	588,235 +inf%	17.00	9,999,995 USD
2021-04-23	2021-04-21	B Purchase	ORBIMED ADVISORS LLC Major owner	235,000 +inf% 17.00 3,995,000 USD	235,000 +inf%	17.00	3,995,000 USD
2021-04-23	2021-04-21	B Purchase	Accelmed Partners II L.P. Major owner	588,235 +inf% 17.00 9,999,995 USD	588,235 +inf%	17.00	9,999,995 USD
2021-04-23	2021-04-21	B Purchase	Fischer Frank M Non-Executive Director	50,000 +115.5% 17.00 850,000 USD	50,000 +115.5%	17.00	850,000 USD
2021-04-23	2021-04-21	B Purchase	Garfield Greg Shaw Non-Executive Director	13,235 +51.7% 17.00 224,995 USD	13,235 +51.7%	17.00	224,995 USD
2021-04-23	2021-04-21	B Purchase	Ridley Irina General Counsel and Secretary Officer	2,352 +inf% 17.00 39,984 USD	2,352 +inf%	17.00	39,984 USD